Cyto Flashcards
what is the purpose of the new CNV (2019) guidelines?
the guidelines introduce a semi-quantitative, evidence-based framework with a 5-tier classification system with separate schemes for gains and losses. The aim was to provide consistent, evidence-based clinical classification across labs.Pathogenic 0.99 or higherLikely pathogenic 0.90 to 0.98Uncertain significance -0.89 to 0.89Likely benign -0.90 to -0.98Benign -0.99 or fewer
what is involved in CNV assessment?
CNV genomic content: size,overlap with established triplosensitive (TS), haploinsufficient (HI) or benign genes/genomic regions; gene number and content population frequency, evaluation of literature, public databases, internal lab data; inheritance pattern/family history for patient being studied
give examples of recurrent CNV syndromes caused by low-copy repeats which may misalign during recombination at meiosis
Prader-Willi / Angelman syndromes 15q11q13DiGeorge/velocardiofacial syndrome 22q11.21 deletion including TBX1Williams syndrome 7q11.23 deletion including ELNSmith-Magenis syndrome 17p11.2 deletion including RAI1Miller-Dieker syndrome 17p13.3 deletion including PAFA1B1 and YHWAE
why should number of protein-coding genes in a CNV be assessed?
• CNVs containing no protein-coding genes or other known functionally important elements are more likely to be benign.• a small CNV in a gene-rich region could have a larger impact than a much larger CNV in a gene-poor region. ACMG guidelines suggest adding evidence if ≥25 genes for copy number loss and ≥35 genes for copy number gains. Consideration should be given for clusters of genes where a relatively large number of genes may be present with little phenotype impact e.g. olfactory receptor gene clusters
why might Pathogenic CNVs may also be present at low frequency in control populations ?
recessive inheritance, incomplete penetrance, parent of origin effect, late onset phenotypes and affected individuals in poorly phenotyped control cohorts
name sources for population frequency of CNVs
DGV - The DGV Gold is a curated set of variants from selected high resolution and high quality studies in DGV, clustering variants and removing low-resolution studies with high false-positive rates GnoMad SVo In-house laboratory database of normal control samples can be useful to identify common variants in a local population and/or technical artefacts that may be platform specific.
what kinds of evidence might aid CNV interpretation?
- multiple unrelated patients with a similar CNV and a consistent phenotype (more likely pathogenic)- de novo supports pathogenicity. Additional weight is given if the phenotype is highly specific and relatively unique to the gene/genomic region.- Segregation amongst similarly affected family members supports pathogenicity• Non-segregations EXCEPT incomplete penetrance, phenocopies (variation caused by environment that resembles a genetic variation), accurate phenotyping of family members, age of onset and inheritance pattern - for a CNV identified in recessive gene - look for SNV on other allele
what is haploinsufficiency? how can it be found for a gene?
loss of one allele resulting in a single normal allele at a particular locus is inadequate for normal function resulting in a phenotype. Regions of copy number loss containing established HI genes are more likely to be pathogenic. HI info available on ClinGen, decipher, knockout mouse models, literature, ClinVar, HGMD, OMIMpLI available on GnoMad
what are intergenic deletions and could they be pathogenic?
do not affect the coding sequence of a gene. may be pathogenic if disrupt regulation of expression of nearby genes An intergenic deletion in close proximity to a known OMIM morbid gene with a relevant phenotype may warrant further investigation.intragenic dels affecting the 5’ or 3’UTR, or are entirely within an intron, is less clear, but it is possible that such deletions could affect RNA transcription, splicing, stability, or translation.
what is Triplosensitivity (TS)? how is it assessed?
where an additional copy of a gene/genomic region results in a phenotype. Fewer genes appear to exhibit TS than HI and therefore copy number gains are more likely to result in a milder phenotype or to be benign than the reciprocal deletion. clingen, literature and database searching show TS.
why might 5’ or 3’ duplications be pathogenic?
may disrupt regulatory elements
why is it important to determine the source of a homozygous dup?
Homozygous duplications manifest as a copy number of 4, which could also represent a heterozygous triplication. Parental studies are therefore necessary to determine whether the imbalance is monoallelic or biallelic. A biallelic gene-disrupting duplication can be causative of a recessive disorder, whereas a monoallelic triplication cannot be associated with a recessive disorder but may cause disease through a different mechanism.
What are the three types of cell culture systems available?
Direct preparation - no culturing performedSuspension - cells in media in tubes/flasksIn-situ - cells cultured on a coverslip and colonies form
What supplements can be added to the culture medium to promote growth?
L-glutamineFoetal calf serumAntibioticsAntifungals
What mitogens are available to stimulate cell growth? Which cell types do they stimulate?
PHA - T cell stimulationPWM - B cell and T-cell stimulationLPS - B-cell stimulation (used for patients with chronic lymphoproliferative disordersTPA - B cell stimulation
How long are Bone Marrow cultures routinely cultured for?
12/48hours
How long are AF/CVS samples cultured for?
5-7 days, undisturbed
What additional step needs to be performed prior to BM culture?
White Cell Count
Name three Chromosome Breakage syndromes. State which gene is mutated in each.
Fanconi Anaemia - 15 genesAtaxia Telangiectasia - ATMBloom syndrome - BLMXeroderma Pigmentosa - multigenic
What chemicals/treatments can be used to highlight chromosome breakage in culture?
MMC or DOB - they crosslink the DNA and enhance the rate of breaks. This can be used to diagnose FA or AT.UV-light - induces increased SCE in Bloom syndrome. Detected by adding BrdU to culture and G-banding.
How can the identification of a balanced translocation lead to new gene discovery?
Gene interruption (DMD, SOTOS)Result in submicroscopic deletions/duplications (CHARGE syndrome)Gene removed from cis-acting elements by balanced translocation (PAX6 in Aniridia)Gene translocated next to an enhancer (BCR-ABL1, t(9;22)(q34;q11))
How can recurrent deletions/duplications leads to gene identification?
Microdeletions can narrow down a region linked to disease. Study genes in these regions to identify possible cause. - Miller Dieker (17p13.3), LIS1